June: New Drug Approvals by the NMPA - May 2024

•  
• Imported drugs:
• □　Botulinum toxin type A for injection marketed by AbbVie Limited
• □　Fludrocortisone acetate tablets marketed by ASPEN PHARMA TRADING LIMITED
• □　Lidocaine cataplasms marketed by Teikoku Pharma USA, Inc.
• □　Octreotide acetate injection (Brand name: Sandostatin) marketed by Novartis Pharma Schweiz AG
• □　Pitolisant hydrochloride tablets marketed by Bioprojet Pharma
• □　Repotrectinib capsules (Brand name: Augtyro) marketed by Bristol-Myers Squibb Company
• □　Sulbactam sodium / durlobactam sodium injection (Brand name: Xacduro) marketed by Entasis Therapeutics, Inc.
• □　Tirzepatide Injection (Brand name: Mounjaro) marketed by Eli Lilly and Company

 

• Domestic drugs:
• □　Allisartan isoproxil and amlodipine besylate tablets (Brand name: 复立坦 (Fu Li Tan)) marketed by Shenzhen Salubris Pharmaceuticals Co., Ltd.
• □　Anlotinib hydrochloride capsules (Brand name: 福可维 (Fu Ke Wei)) marketed by CTTQ Pharma
• □　Compound sodium acetate and glucose injection marketed by En Tai Pharmaceutical
• □　Crisugabalin besilate capsules (Brand name: 思美宁 (Si Mei Ning)) marketed by Haisco Pharmaceutical Group
• □　Denosumab injection (Brand name: 博洛加 (Bo Luo Jia)) marketed by Boan Biotech
• □　Esomeprazole magnesium and sodium bicarbonate capsules marketed by Encheng Group
• □　Fluocinolone acetonide, hydroquinone and tretinoin cream marketed by Zhejiang Fonow Medicine Co., Ltd.
• □　Fluzoparib capsules (Brand name: 艾瑞颐 (Ai Rui Yi)) marketed by Jiangsu Hengrui Pharmaceuticals Co., Ltd.
• □　Human prothrombin complex marketed by Weiguang Biological
• □　Ivonescimab injection (Brand name: 依达方 (Yi Da Fang)) marketed by Akeso, Inc.
• □　Lansoprazole and sodium bicarbonate capsules marketed by Encheng Group
• □　Metoprolol succinate sustained-release capsules marketed by Cisen Pharmaceutical Co., Ltd.
• □　Mixed protamine zinc recombinant insulin lispro injection (50R) marketed by Wanbang Biopharma
• □　Rezivertinib mesylate capsules (Brand name: 瑞必达 (Rui Bi Da)) marketed by Beta Pharma
• □　Tacrolimus granules marketed by Huadong Medicine Co., Ltd.
• □　Zanubrutinib capsules (Brand name: 百悦泽 (Brukinsa)) marketed by BeiGene, Ltd.

 

• (Source: BaiPharm)